Reach Us +44-1202-068036
Extensive Dynamic Changes In Omics Profiles During Normal And Disease States | 7998
ISSN: 2153-0769

Metabolomics:Open Access
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Extensive dynamic changes in omics profiles during normal and disease states

International Conference and Exhibition on Metabolomics & Systems Biology

Michael Snyder

Keynote: J Comput Sci Syst Biol

DOI: 10.4172/0974-7230.S1.01

Genomic medicine will require the integrated analysis of genomic information and omics information. We have determined the genome sequence of an individual at high accuracy and performed an integrated analysis of omics profiles during normal and virally infected states. Omics profiling of transcriptomes, proteomes, cytokines, metabolomes and autoantibody omes have revealed dynamic and broad changes in molecular components occur during infection. Analysis of heteroallelic expression suggests significant changes in differential allele expression in healthy and disease states. Analyses of information about coding and regulatory information led to predictions of disease risk; some were subsequent validation through omics and medical profiles. Our study is the first torelatepersonal genomic information to global functional omicsactivity for physiological and medical interpretation of healthy and disease states.

Michael Snyder is the Chairman of Genetics and the Director of the Center for Genomics and Personalized Medicine at Stanford. Dr. Snyder received his Ph.D. training at CalTech and carried out postdoctoral training at Stanford. His laboratory study was the first to perform a large-scale functional genomics project in any organism, and has launched many technologies in genomics and proteomics. These include the development of proteome chips, high resolution tiling arrays for the entire human genome, methods for global mapping of transcription factor binding sites, paired end sequencing for mapping of structural variation in eucaryotes, and RNA-Seq. These technologies have been used for characterizing genomes, proteomes and regulatory networks.

Leave Your Message 24x7